Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale. The study, conducted in partnership by researchers at Nemours Children’s Hospital and the University of Central Florida, demonstrates a potentially novel treatment for neuroblastoma, the most common cancer in infants.
“High-risk neuroblastoma can be resistant to traditional therapy, and survival can be poor. This research demonstrates a novel method of treating this tumor without the toxicity of aggressive therapy that can also have late effects on the patient’s health,” said Tamarah J. Westmoreland, MD, PhD, a pediatric surgeon at Nemours Children’s Health System and senior author of the study. “Unique approaches to target tumor cells with nanoparticle delivery systems hold promise for treatment of resistant tumors, such as the high risk neuroblastoma. We are hopeful that in the future, nanoparticles can be utilized to personalize care to patients and reduce the late effects of therapy.”
Neuroblastomas are cancers that start in early nerve cells and commonly form in the tissue of the adrenal glands, near the kidneys. About 700 new cases of neuroblastoma are diagnosed each year in the United States and most cases appear in children younger than 5 years old. High-risk neuroblastoma is hard to cure and is more likely to become resistant to standard therapies or recur. These cancers are also associated with late effects after treatments have ended, including developmental delays, hearing loss, or other disabilities.
Curcumin has been shown to have substantial anti-cancer ability, but its low solubility and poor stability have made its use in medicinal applications challenging. Researchers from Nemours and UCF found that nanoparticles can be used to deliver curcumin to tumor sites.
“This shows that nanoparticles can be an effective delivery vehicle for cancer drugs,” said Professor Sudipta Seal, who directs of UCF’s NanoScience Technology Center and Advanced Materials Processing Analysis Center, and is a collaborator on the study. “More research is needed, but we are hopeful it could lead to more effective treatment of this devastating disease in the future.”
In the study, researchers loaded Cerium oxide nanoparticles with curcumin and coated them with dextran to test in cell lines of a high-risk form of neuroblastoma, known as MYCN-amplified, as well as non-amplified neuroblastoma. This formulation induced substantial cell death in neuroblastoma cells while producing no or only minor toxicity in healthy cells. Overall, the nano-therapeutic treatments showed a more pronounced effect in MYCN-amplified cells, which are traditionally more resistant to drug therapies.
Nanoscience research, which explores the unusual properties of materials at the nanoscale, has led to advancements in medicine, energy, information storage, computing and other fields. At no more than 100 nanometers, nanoparticles are exceedingly small. By comparison, a sheet of paper is about 75,000 nanometers thick.
This study was conducted in a laboratory setting in Orlando, at Nemours Children’s Hospital and the University of Central Florida in cells from children with neuroblastoma, but researchers hope to begin to use these curcumin nanoparticles with micro RNA in animal models to direct the molecule to a tumor site.
The Latest on: Neuroblastoma
FDA tags Cellectar's CLR 131 an Orphan Drug for neuroblastoma; shares up 9% after hours
on March 16, 2018 at 5:42 pm
Thinly traded nano cap Cellectar Biosciences (NASDAQ:CLRB) is up 9% after hours on increased volume in response to the FDA designating PET imaging agent CLR 131 (18-(p--iodophenyl)octadecyl phosphocholine) an Orphan Drug for neuroblastoma , a ... […]
Great Wolf Lodge partners to help fight cancer
on March 13, 2018 at 1:36 pm
Alex Scott was born in 1996 and diagnosed with Neuroblastoma before she turned one, according to the foundation’s website. When she was hospitalized at four years old, she told her mother, Liz Scott, she wanted to have a lemonade stand to help other kids ... […]
Study identifies two new biomarkers for common form of childhood cancer
on March 13, 2018 at 5:03 am
Two new biomarkers for a type of cancer in children called neuroblastoma have been identified in a study published in the journal Cancer Cell. The findings are expected to have immediate significance for disease prognosis, and eventually also for treatment. […]
Four-Year-Old Armenian Boy Fighting Cancer Needs Help
on March 12, 2018 at 1:50 pm
Little Areg Khachatryan turned four on March 10, just one day after his sixth round of chemotherapy. The young boy, who was diagnosed with neuroblastoma last August, has more rounds of chemotherapy under his belt than years of life. Neuroblastoma is a rare ... […]
X Factor star Emily Middlemas pens heartbreaking song for tragic three-year-old Glasgow tot Layla Greene who died from neuroblastoma
on March 12, 2018 at 6:30 am
X FACTOR star Emily Middlemas has written a song for tragic tot Layla Greene who passed away after a fight with neuroblastoma – with all proceeds going to the cancer charity. Three-year-old Layla, from Renfrew, became pals with Middlemas after attending ... […]
Trucker Dukes’ Week: Events Held in Honor of Maui Boy
on March 9, 2018 at 12:41 pm
Trucker passed away after a hard fought battle with Neuroblastoma in March 2017. The events this week will raise funds for individuals with cancer by bringing together a community of resources to support them, while also helping fund innovative research ... […]
Olympic champ Helen Maroulis visits with 11-year-old wrestler Mikey Schneider who is fighting cancer
on March 8, 2018 at 4:44 pm
His opponent this time? Stage 4 Cancer. Metastatic Neuroblastoma, the cancer Mikey has been diagnosed with, is a cancer of the nervous system that was discovered arising from his adrenal gland. Since his initial diagnosis, additional tests have revealed ... […]
Fighting Cancer With Cookies? There’s a Charity For That
on March 8, 2018 at 1:12 pm
At the time, he was in remission from neuroblastoma, a rare cancer of the nervous system and the family was looking for a way to pay it forward. Staging a version of the classic fundraiser, a bake sale, they took it to epic proportions, raising $420,000 ... […]
R.I. senator leads fight against childhood cancer
on March 7, 2018 at 9:05 pm
Reed began working on the issue of childhood cancer after meeting a family whose son had passed away at age nine from neuroblastoma, an aggressive brain cancer. He first proposed legislation on the issue with the Caroline Pryce Walker Conquer Childhood ... […]
A new target for neuroblastoma
on February 14, 2018 at 12:00 am
Neuroblastoma — a cancer that starts in nerve tissue outside of the brain — is the third most common cancer in children and accounts for about 15 percent of pediatric cancer-related deaths. Sirtuins (SIRTs), a family of proteins with roles in ... […]
via Google News and Bing News